The Sepsis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for the Sepsis Global Market Report 2025 has seen robust growth in recent times. It is predicted to expand from $0.93 billion in 2024 to $1.02 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%.
The sepsis market is projected to reach $1.44 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.0%.
Download Your Free Sample of the 2025 Sepsis Market Report and Uncover Key Trends Now!The key drivers in the sepsis market are:
• Increasing adoption of artificial intelligence in critical care
• Rising prevalence of multidrug-resistant infections
• Growing awareness campaigns about sepsis
• Expanding healthcare infrastructure in emerging economies and increasing investments in biotechnology and pharmaceutical research
The sepsis market covered in this report is segmented –
1) By Type: Diagnosis, Therapeutics
2) By Pathogen: Bacterial, Viral, Fungal
3) By Application: Severe Sepsis, Septic Shock
4) By End User: Hospitals, Pathology, Reference Laboratories
Subsegments:
1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods
2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options
The key trends in the sepsis market are:
• The adoption of artificial intelligence in critical care is shaping the sepsis global market.
• The utilization of rapid point-of-care diagnostics is becoming an emerging trend.
• Personalized antibiotic stewardship programs are increasingly trending in the sepsis market.
• The development of novel therapies targeting immune modulation is influencing the future of the market.
Major players in the sepsis market are:
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Merck KGaA
• Bayer AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Novartis AG
• Siemens AG
• Asahi Kasei Corporation
• Becton, Dickinson and Company
• bioMérieux SA
• QuidelOrtho Corporation
• Diasorin S.p.A.
• Innoviva Inc.
• Seegene Inc.
• EKF Diagnostics
• Boditech Med Inc.
• Cytovale Inc.
• Alifax S.r.l.
• Hansa Biopharma
• Amomed Pharma GmbH
• Inotrem S.A.
• Abionic SA
• Biosystems Inc.
• Immunexpress Inc.
North America was the largest region in the sepsis market in 2024